Bristol-Myers Squibb Co.

BMYNYSE • USD
61.69 USD
↘ 1.11 (1.77%)🟢LIVE (AS OF 11:34 AM EST)
🟢Market: OPEN

Bristol-Myers Squibb Co. (BMY) trades at $61.69 per share. The stock presents a bullish profile across the board: both technical indicators and our fundamental models signal a "Strong Buy" and "Buy" respectively. Key drivers include exceptional Return on Equity (41.6%) and a bullish Golden Cross on the moving averages. On the valuation side, BMY appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 10, 2026.

Open?$62.00
High?$62.45
Low?$61.33
Prev. Close?$62.80
Volume?1.9M
Avg. Volume?11.9M
VWAP?$61.63
Rel. Volume?0.16x
Bid / Ask
Bid?$61.69 × 400
Ask?$61.71 × 100
Spread?$0.02
Midpoint?$61.70
Valuation & Ratios
Market Cap?128.4B
Shares Out?2.0B
Float?2.0B
Float %?98.1%
P/E Ratio?13.83
P/B Ratio?5.75
EPS?$4.54
Dividend?3.97%
Ex-Dividend?N/A
News
Profile
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Employees
32.5K
Market Cap
128.4B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1952-06-23
Address
ROUTE 206 AND PROVINCE LINE ROAD
PRINCETON, NJ 08543
Phone: (609) 252-4621
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
59
Momentum?
77
Short Sent.?
83
Piotroski F-Score?5/9Mixed
Altman Z-Score?2.64Grey
Confidence?80%High
Full Fundamental Analysis →
Short InterestModerate
Short % of Float?2.34%Low
Short Interest?46.8M
Days to Cover?4.2
Free Float2.0B
Avg Daily Volume11.1M
Settlement Date2026-10-30
Financial Health
Current Ratio?1.53Adequate
Quick Ratio?1.38Adequate
Cash Ratio?0.47Low
Debt/Equity?1.93High
ValuationATTRACTIVELY VALUEDvs 10 peers + S&P 500
Score
89/100
P/E?
Peers
100
S&P
85
13.8CHEAP▾
P/B?
Peers
90
S&P
32
5.75FAIR▾
P/S?
Peers
100
S&P
56
2.61CHEAP▾
P/FCF?
Peers
100
S&P
85
11.2CHEAP▾
EV/EBITDA?
Peers
91
S&P
74
10.9CHEAP▾
EV/Sales?
Peers
100
S&P
56
3.31FAIR▾
Returns & Efficiency
ROE?
Peers
67
S&P
89
41.6%STRONG▾
ROA?
Peers
70
S&P
76
10.6%STRONG▾
Cash Flow & Enterprise
FCF?$11.4B
Enterprise Value?$162.8B
Fundamentals ratios updated end of day